Primary Sjögren's syndrome (pSS) is a relatively common autoimmune systemic rheumatic
disease. In addition to sicca syndrome and swollen salivary glands, systemic features …

Sjögren's syndrome is a common autoimmune disease (affecting∼ 0.7% of European
Americans) that typically presents as keratoconjunctivitis sicca and xerostomia. Here we …

Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid
arthritis. The Oral Rheumatoid Arthritis triaL (ORAL) Strategy aimed to assess the …

Objective To evaluate the efficacy and safety of ustekinumab in 3 randomized, placebo‐
controlled studies in patients with axial spondyloarthritis (SpA). Studies 1 and 2 included …

Spreading of the immune response is a common theme in organ‐specific and systemic
autoimmune diseases. We evaluated whether some of the mixed antinuclear antibody …

Characterisation of autoantibodies and their target autoantigens in primary Sjögren's
syndrome (SS) is an important entry point for studying this common systemic autoimmune …

Objective Sjögren's syndrome (SS) is an autoimmune disorder characterized by dry eyes
and mouth (sicca syndrome) and lymphocytic infiltration of the lacrimal and salivary glands …

Objective The SELECT‐EARLY trial was undertaken to study the effect of upadacitinib, an
oral, reversible Janus kinase 1–selective inhibitor, as monotherapy in patients with …

Background Upadacitinib is an oral selective Janus kinase inhibitor to treat rheumatoid
arthritis. The efficacy and safety of upadacitinib as compared with abatacept, a T-cell …

Objectives To analyse the influence of geolocation and ethnicity on the clinical presentation
of primary Sjögren's syndrome (SjS) at diagnosis. Methods The Big Data Sjögren Project …